Brady Todd C
SEC CIK 1579179 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ALDX | Aldeyra Therapeutics, Inc. | Pres, CEO, Dir | 1.72M | $477.9K | $580.4K | 7 | 2022-03-30 | 2026-06-03 |
Most active insiders at ALDX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Brady Todd C | Pres, CEO, Dir | $418.4K | — |
| 2 | DOUGLAS RICHARD | Dir | $98.0K | — |
| 3 | Alfieri Michael | Principal Financial Off | $7,100 | — |
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-05 16:19 | 2026-06-03 | ALDX | Aldeyra Therapeutics, Inc. | Brady Todd C | Pres, CEO, Dir | P - Purchase | $1.67 | +250.0K | 1.72M | +17% | +$418.4K | |
| DM | 2024-03-12 | 2024-03-11+ | ALDX | Aldeyra Therapeutics, Inc. | Brady Todd C | Pres, CEO, Dir | S - Sale | $3.17 | -183.2K | 1.47M | -11% | -$580.4K |
| DM | 2023-09-11 | 2023-09-07 | ALDX | Aldeyra Therapeutics, Inc. | Brady Todd C | Pres, CEO, Dir | M - OptEx | $0.55 | +273.1K | 1.68M | +19% | +$150.2K |
| D | 2023-09-11 | 2023-09-07 | ALDX | Aldeyra Therapeutics, Inc. | Brady Todd C | Pres, CEO, Dir | F - Tax | $7.22 | -73.8K | 1.65M | -4% | -$532.9K |
| D | 2023-03-02 | 2023-02-28 | ALDX | Aldeyra Therapeutics, Inc. | Brady Todd C | Pres, CEO, Dir | A - Grant | $0.00 | +238.8K | 1.46M | +20% | $0 |
| 2022-06-27 | 2022-06-23 | ALDX | Aldeyra Therapeutics, Inc. | Brady Todd C | Pres, CEO, Dir | P - Purchase | $3.36 | +17.7K | 1.22M | +1% | +$59.5K | |
| D | 2022-04-01 | 2022-03-30 | ALDX | Aldeyra Therapeutics, Inc. | Brady Todd C | Pres, CEO, Dir | A - Grant | $0.00 | +250.0K | 1.20M | +26% | $0 |
Purchase Sale Sale after option exercise All abbreviations